Connecting Patients to Breakthrough Treatments

Early Access Care provides a bridge for patients with serious or life-threatening diseases to gain access to breakthrough investigational medicines when no other treatment options are available. Our industry experts guide biopharma companies in implementing compassionate use programs and work directly with physicians to expedite access to experimental therapies. With over 50 years of drug development experience and expertise navigating regulatory requirements worldwide, we streamline the process so biopharma companies can focus on clinical trials while bringing hope to patients in need.

Our proprietary Early Access System platform enables efficient management of expanded access programs from request to approval to delivery of the investigational drug. We also provide real-world data insights that can potentially accelerate experimental treatments to market. At Early Access Care, we are driven by our mission to connect patients globally with the promise of cutting-edge science when it matters most.